BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 337 filers reported holding BIONTECH SE in Q3 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,162,155 | +8.1% | 84,335 | +7.4% | 0.00% | 0.0% |
| Q2 2023 | $8,476,283 | -7.0% | 78,535 | +7.3% | 0.00% | -33.3% |
| Q1 2023 | $9,113,542 | -10.4% | 73,160 | +8.0% | 0.00% | 0.0% |
| Q4 2022 | $10,174,250 | +2.2% | 67,729 | -8.3% | 0.00% | 0.0% |
| Q3 2022 | $9,958,000 | -4.3% | 73,831 | +5.8% | 0.00% | 0.0% |
| Q2 2022 | $10,408,000 | -14.2% | 69,813 | -1.8% | 0.00% | 0.0% |
| Q1 2022 | $12,130,000 | -32.0% | 71,112 | +2.7% | 0.00% | -25.0% |
| Q4 2021 | $17,843,000 | +769.1% | 69,212 | +820.6% | 0.00% | +300.0% |
| Q3 2021 | $2,053,000 | +48.0% | 7,518 | +21.4% | 0.00% | – |
| Q2 2021 | $1,387,000 | -16.8% | 6,195 | -69.7% | 0.00% | – |
| Q4 2020 | $1,668,000 | -95.9% | 20,468 | -96.6% | 0.00% | -100.0% |
| Q3 2020 | $41,183,000 | +528.9% | 594,872 | +506.3% | 0.01% | +600.0% |
| Q2 2020 | $6,548,000 | – | 98,113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |